Search results for "Spinal cord injury"

showing 10 items of 82 documents

Targets and dimensions of social comparison among people with spinal cord injury and other health problems

2006

The present research examined comparison targets and comparison dimensions among two Spanish samples of individuals facing serious illnesses and diseases. In Study 1, 90 older patients (mean age 66.36) with various age-related diseases, particularly cardiovascular diseases and diabetes, indicated that they compared themselves most often with others with the same disease, next with others with another disease and least with people without health problems. They compared themselves more often on their mental state, symptoms and physical activities than on their social activities. Social comparison orientation (SCO) as an individual difference characteristic was associated with more frequent co…

MaleHealth Statusmedia_common.quotation_subjectMEDLINEPsychological interventionAFFILIATIONUNCERTAINTYCANCER-PATIENTSDiseaseADJUSTMENTDevelopmental psychologyPSYCHOLOGYSurveys and QuestionnairesNEUROTICISMmedicineHumansPersonalitySpinal cord injurySpinal Cord InjuriesCOMPARISON INFORMATIONApplied PsychologyAgedCOMPARISON ORIENTATIONmedia_commonSocial comparison theorySocial perceptionGeneral Medicinemedicine.diseaseNeuroticismINDIVIDUALSSocial PerceptionFemalePsychologyAttitude to HealthRESPONSESClinical psychologyBritish Journal of Health Psychology
researchProduct

Erythropoietin and erythropoietin receptor expression after experimental spinal cord injury encourages therapy by exogenous erythropoietin

2005

OBJECTIVE: Erythropoietin (EPO) is a pleiotropic cytokine originally identified for its role in erythropoiesis. Recent studies have demonstrated that EPO and its receptor (EPO-R) are expressed in the central nervous system, where EPO exerts neuroprotective functions. Because the expression of the EPO and EPO-R network is poorly investigated in the central nervous system, the aim of the present study was to investigate whether the resident EPO and EPO-R network is activated in the injured nervous system. METHODS: A well-standardized model of compressive spinal cord injury in rats was used. EPO and EPO-R expression was determined by immunohistochemical analysis at 8 hours and at 2, 8, and 14 …

MaleNervous systemmedicine.medical_specialtyCentral nervous systemSpinal cord injuryNeuroprotectionErythropoietin receptorRats Sprague-Dawleyhemic and lymphatic diseasesInternal medicineReceptors ErythropoietinmedicineAnimalsSpinal cord injuryErythropoietinSpinal Cord InjuriesNeuronsbusiness.industryNervous tissuemedicine.diseaseAneurysmRecombinant ProteinsNeuroprotectionRatsErythropoietin receptorDisease Models Animalmedicine.anatomical_structureEndocrinologyGene Expression Regulationerythropoietin; erythropoietin receptor; neuroprotection; spinal cord injuryErythropoietinImmunologyNeurogliaSurgeryNeurology (clinical)businessSpinal Cord Compressionmedicine.drug
researchProduct

Risk factors in iatrogenic spinal cord injury

2017

Study design: In the last years, there has been a change in the aetiology of spinal cord injury. There has been an increase in the number of elderly patients with spinal cord injuries caused by diseases or medical procedures. Objective: The aim of this study is to investigate the frequency of the occurrence of iatrogenic spinal cord injury in our unit. The secondary aim is to study what variables can be associated with a higher risk of iatrogenesis. Methods: A retrospective, descriptive, observational study of patients with acute spinal cord injury admitted from June 2009 to May 2014 was conducted. The information collected included the patient age, aetiology, neurological level and grade o…

MaleSURGERYIatrogenic DiseaseDISEASE0302 clinical medicineRisk FactorsINFECTIONOdds Ratio030212 general & internal medicineChildSpinal cord injuryDepression (differential diagnoses)Aged 80 and overCOMPLICATIONSAge FactorsGeneral MedicineMiddle AgedDEPRESSIONmedicine.anatomical_structureNeurologyCardiovascular DiseasesOF-THE-LITERATUREChild PreschoolSURGICAL-TREATMENTAnesthesiaFemaleAdultAdolescentPATIENTIatrogenesisYoung Adult03 medical and health sciencesmedicineHumansMedical historySpinal Cord InjuriesAgedRetrospective Studiesbusiness.industryPARAPLEGIAEPIDURAL HEMATOMARetrospective cohort studyOdds ratiomedicine.diseaseSpinal cordLogistic ModelsNeurology (clinical)businessComplication030217 neurology & neurosurgerySpinal Cord
researchProduct

Neuroprotection by erythropoietin administration after experimental traumatic brain injury.

2007

A large body of evidence indicates that the hormone erythropoietin (EPO) exerts beneficial effects in the central nervous system (CNS). To date, EPO's effect has been assessed in several experimental models of brain and spinal cord injury. This study was conducted to validate whether treatment with recombinant human EPO (rHuEPO) would limit the extent of injury following experimental TBI. Experimental TBI was induced in rats by a cryogenic injury model. rHuEPO or placebo was injected intraperitoneally immediately after the injury and then every 8 h until 2 or 14 days. Forty-eight hours after injury brain water content, an indicator of brain edema, was measured with the wet-dry method and bl…

MaleTime FactorsBrain EdemaFunctional LateralityRats Sprague-Dawleychemistry.chemical_compoundTraumatic brain injuryMedicineAnalysis of Variance Animals Blood-Brain Barrier; drug effects Brain Edema; drug therapy/etiology Brain Infarction; drug therapy/etiology Brain Injuries; complications/drug therapy Disease Models; Animal Erythropoietin; administration /&/ dosage Evans Blue; diagnostic use Functional Laterality Humans Male Neurologic Examination Neuroprotective Agents; administration /&/ dosage Rats Rats; Sprague-Dawley Reaction Time; drug effects Recombinant Proteins Time Factorsadministration /&/ dosageSpinal cord injuryEvans BlueNeurologic ExaminationGeneral Neuroscienceexperimental models of brain and spinal cord injuryExtravasationNeuroprotectionRecombinant Proteinsmedicine.anatomical_structureNeuroprotective AgentsBlood-Brain BarrierAnesthesiadiagnostic usemedicine.drugEvans BlueBrain InfarctionTraumatic brain injuryCentral nervous systemrecombinant human EPO (rHuEPO)PlaceboNeuroprotectionReaction TimeAnimalsHumansMolecular BiologyErythropoietinAnalysis of VarianceNeuroscience (all)business.industryAnimaldrug therapy/etiologymedicine.diseaseRatsDisease Models AnimalchemistryErythropoietindrug effectsBrain InjuriesDisease Modelsrecombinant human EPO (rHuEPO); experimental models of brain and spinal cord injury; NeuroprotectionNeurology (clinical)Sprague-Dawleybusinesscomplications/drug therapyDevelopmental BiologyBrain research
researchProduct

Effects of Constant and Doublet Frequency Electrical Stimulation Patterns on Force Production of Knee Extensor Muscles

2016

International audience; This study compared knee extensors' neuromuscular fatigue in response to two 30-minute stimulation patterns: constant frequency train (CFT) and doublet frequency train (DFT). Fifteen men underwent two separate sessions corresponding to each pattern. Measurements included torque evoked by each contraction and maximal voluntary contractions (MVC) measured before and immediately after the stimulation sessions. In addition, activation level and torque evoked during doublets (Pd) and tetanic contractions at 80-Hz (P80) and 20-Hz (P20) were determined in six subjects. Results indicated greater mean torque during the DFT stimulation session as compared with CFT. But, no dif…

MalecontractionsMuscle PhysiologyCritical Care and Emergency MedicineContraction (grammar)Knee JointRefractory Period ElectrophysiologicalPhysiologyRefractory periodKneeslcsh:MedicineStimulationKnee JointsIsometric exerciseElectromyographyPathology and Laboratory MedicineEndoplasmic Reticulum0302 clinical medicineNuclear magnetic resonanceMedicine and Health Scienceslcsh:ScienceSpinal Cord InjuryMusculoskeletal SystemTrauma MedicinePhysicsSecretory PathwayMultidisciplinarymedicine.diagnostic_test[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]PhysicsClassical MechanicsAnatomyNeurologyCell ProcessesPhysical SciencesMuscle FatigueLegsspinal-cord-injuryAnatomyCellular Structures and Organellesmedicine.symptomadaptationsTraumatic InjuryindividualsResearch ArticleMuscle ContractionMuscle contractionAdulthuman skeletal-muscleSurgical and Invasive Medical ProcedurestrainsMotion03 medical and health sciencesSigns and SymptomsDiagnostic MedicineIsometric ContractionSarcoplasmic Reticula[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]medicineHumansFunctional electrical stimulationMuscle SkeletalpotentiationFunctional Electrical StimulationMuscle fatigueElectromyographylcsh:RLimbs (Anatomy)Biology and Life SciencesCell Biology030229 sport sciencesElectric StimulationJoints (Anatomy)Torquerecruitmentresponseslcsh:Qfatigue030217 neurology & neurosurgery
researchProduct

Modular megaprosthesis reconstruction for oncological and non-oncological resection of the elbow joint

2016

Abstract Background Reconstruction of large bone defects around the elbow joint is surgically demanding due to sparse soft tissue coverage, complex biomechanics and the close proximity to neurovascular structures. Modular megaprostheses are established reconstruction tools for the elbow, but only small case series have been reported in the literature. Methods Thirty-six patients who underwent reconstruction of the elbow joint with a modular megaprosthesis were reviewed retrospectively. In 31 patients (86.1%), elbow replacement was performed after resection of a bone tumour, whereas five non-oncological patients (13.9%) underwent surgery because of a previous failed elbow reconstruction. Fun…

Malemedicine.medical_treatmentElbowComplex fractureBone tumour; Complex fracture; Distal humerus; Elbow; Modular megaprosthesis; ReconstructionProsthesis0302 clinical medicineElbow JointElbow030212 general & internal medicineRange of Motion ArticularChildGeneral Environmental ScienceAged 80 and over030222 orthopedicsPalsyBiomechanicsSoft tissueModular megaprosthesisMiddle AgedProsthesis FailureTreatment Outcomemedicine.anatomical_structureBone tumourPatient Satisfaction10046 Balgrist University Hospital Swiss Spinal Cord Injury CenterFemaleDistal humerusAdultmusculoskeletal diseasesmedicine.medical_specialtyAdolescentIntra-Articular Fractures610 Medicine & healthBone NeoplasmsProsthesis DesignProsthesis ImplantationYoung Adult03 medical and health sciences2732 Orthopedics and Sports MedicinemedicineHumansSurvival rateAgedRetrospective Studiesbusiness.industryPlastic Surgery ProceduresNeurovascular bundleSurgeryGeneral Earth and Planetary SciencesImplantReconstruction2711 Emergency Medicinebusiness
researchProduct

Endothelialization of chitosan porous conduits via immobilization of a recombinant fibronectin fragment (rhFNIII7–10)

2013

Abstract The present study aimed to develop a pre-endothelialized chitosan (CH) porous hollowed scaffold for application in spinal cord regenerative therapies. CH conduits with different degrees of acetylation (DA; 4% and 15%) were prepared, characterized (microstructure, porosity and water uptake) and functionalized with a recombinant fragment of human fibronectin (rhFNIII 7–10 ). Immobilized rhFNIII 7–10 was characterized in terms of amount ( 125 I-radiolabelling), exposure of cell-binding domains (immunofluorescence) and ability to mediate endothelial cell (EC) adhesion and cytoskeletal rearrangement. Functionalized conduits revealed a linear increase in immobilized rhFNIII 7–10 with rhF…

Materials scienceProtein radiolabellingBiomedical EngineeringNeovascularization PhysiologicSpinal cord injuryBiochemistrylaw.inventionBiomaterialsChitosanchemistry.chemical_compoundTissue engineeringlawSpectroscopy Fourier Transform InfraredPolymer chemistryHumansSurface graftingCytoskeletonMolecular BiologyFluorescent DyesChitosanTissue ScaffoldsbiologyThree-dimensional scaffoldsEndothelial CellsDNAGeneral MedicineAdhesionGraftingRecombinant ProteinsFibronectinsProtein Structure TertiaryFibronectinEndothelial stem cellImmobilized ProteinschemistryProtein conformationMicroscopy Electron Scanningbiology.proteinRecombinant DNABiophysicsAdsorptionPorosityBiotechnology
researchProduct

Type IV collagen and its degradation in paralyzed human muscle: Effect of functional electrical stimulation

2000

The purpose of this study was to evaluate the effects of spinal cord injury (SCI) and functional electrical stimulation (FES) of paralyzed muscles on type IV collagen content and proteins involving its degradation, which is initiated by matrix metalloproteinase (MMP)-2 and -9 and regulated by their tissue inhibitors (TIMPs)-2 and -1. Ten SCI subjects participated in an 18-month program of functional electrical stimulation (FES) of their leg muscles. Needle biopsies were taken from the vastus lateralis muscle before and at various times during the training period, and from able-bodied controls. Type IV collagen concentration was unaltered. ProMMP-2 level of SCI subjects before the training p…

Metalloproteinasemedicine.medical_specialtyPhysiologyVastus lateralis musclebusiness.industrySkeletal muscleAnatomymedicine.diseaseCentral nervous system diseaseExtracellular matrixCellular and Molecular NeuroscienceType IV collagenmedicine.anatomical_structureEndocrinologyPhysiology (medical)Internal medicinemedicineFunctional electrical stimulationNeurology (clinical)businessSpinal cord injuryMuscle & Nerve
researchProduct

The Role of Erythropoietin in Neuroprotection: Therapeutic Perspectives

2007

Nervous system diseases are very complex conditions comprising a large variety of local and systemic responses. Several therapeutic agents interfering with all or in part the biochemical steps that ultimately cause neuronal death have been demonstrated to be neuroprotective in preclinical models. However, all the agents so far investigated have inexorably failed in the phase III trials carried out. A large body of evidence suggests that the hormone erythropoietin (EPO), besides its well-known hematopoietic action, exerts beneficial effects in the central nervous system. EPO's effect has been assessed in several experimental models of brain and spinal cord injury thus becoming a serious cand…

Nervous systemEXPERIMENTAL SUBARACHNOID HEMORRHAGECentral nervous systemSIGNAL-TRANSDUCTIONPharmacologyModels BiologicalNeuroprotectionErythropoietin in neuroprotectionNEURONAL APOPTOSISCEREBROSPINAL-FLUIDAnimalsHumansMedicineIN-VIVO EVIDENCEErythropoietinSpinal cord injuryPharmacologyCEREBRAL-ISCHEMIACOMMON BETA-SUBUNITbusiness.industryRECOMBINANT-HUMAN-ERYTHROPOIETIN; GLYCOGEN-SYNTHASE KINASE-3-BETA; EXPERIMENTAL SUBARACHNOID HEMORRHAGE; COMMON BETA-SUBUNIT; IN-VIVO EVIDENCE; CEREBRAL-ISCHEMIA; SIGNAL-TRANSDUCTION; CEREBROSPINAL-FLUID; NEURONAL APOPTOSIS; CYTOKINE RECEPTORSRECOMBINANT-HUMAN-ERYTHROPOIETINmedicine.diseaseRecombinant ProteinsEnzyme ActivationStrokeClinical trialNeuroprotective AgentsTreatment Outcomemedicine.anatomical_structureErythropoietinGLYCOGEN-SYNTHASE KINASE-3-BETACYTOKINE RECEPTORSBone marrowMitogen-Activated Protein Kinasesbusinessmedicine.drugDrug News & Perspectives
researchProduct

Emerging Therapeutic Strategies for Traumatic Spinal Cord Injury

2020

Spinal cord injury (SCI) is a debilitating neurologic condition with tremendous socioeconomic impact on affected individuals and the health care system. The treatment of SCI principally includes surgical treatment and marginal pharmacologic and rehabilitation therapies targeting secondary events with minor clinical improvements. This unsuccessful result mainly reflects the complexity of SCI pathophysiology and the diverse biochemical and physiologic changes that occur in the injured spinal cord. Once the nervous system is injured, cascades of cellular and molecular events are triggered at varying times. Although the cascade of tissue reactions and cell injury develops over a period of days …

Nervous systemmedicine.medical_specialtyCordmedicine.medical_treatmentSpinal cord injuryRegenerative MedicineMesenchymal Stem Cell TransplantationNeuroprotection03 medical and health sciences0302 clinical medicineNeural Stem CellsGlyburideGranulocyte Colony-Stimulating FactormedicineHumansHypoglycemic AgentsIntensive care medicineErythropoietinSpinal cord injurySpinal Cord InjuriesNeuronal PlasticityRehabilitationCombination treatmentsHepatocyte Growth Factorbusiness.industryNeurological RehabilitationDecompression SurgicalSpinal cordmedicine.diseaseNeuroregenerationNeuroprotectionClinical trialFibroblast Growth FactorsClinical trialmedicine.anatomical_structure030220 oncology & carcinogenesisIntercellular Signaling Peptides and ProteinsSurgeryNeuroregenerationSchwann CellsNeurology (clinical)business030217 neurology & neurosurgeryStem Cell TransplantationWorld Neurosurgery
researchProduct